Kunxian capsules in the treatment of patients with ankylosing spondylitis: a randomized placebo-controlled clinical trial

BACKGROUND: Ankylosing spondylitis (AS) is a chronic inflammatory autoimmune disease. Kunxian capsule, a Chinese patent medicine which has been used in the treatment of immunologic diseases for many years in China, has anti-inflammatory and immunoregulatory effects. This study investigates the effic...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Trials
Hlavní autoři: Li, Qiuxia, Li, Li, Bi, Liqi, Xiao, Changhong, Lin, Zhiming, Cao, Shuangyan, Liao, Zetao, Gu, Jieruo
Médium: Artigo
Jazyk:Inglês
Vydáno: BioMed Central 2016
Témata:
Research
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4957347/
https://ncbi.nlm.nih.gov/pubmed/27449221
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13063-016-1438-6
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky